Callan Family Office’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.25M | Buy |
8,740
+2,023
| +30% | +$522K | 0.07% | 259 |
|
|
2025
Q1 | $1.5M | Sell |
6,717
-61
| -0.9% | -$13.7K | 0.11% | 161 |
|
|
2024
Q4 | $1.55M | Buy |
+6,778
| New | +$1.55M | 0.1% | 179 |
|
|
2023
Q2 | – | Sell |
-1,034
| Closed | -$226K | – | 146 |
|
|
2023
Q1 | $226K | Hold |
1,034
| – | – | 0.05% | 148 |
|
|
2022
Q4 | $215K | Buy |
+1,034
| New | +$215K | 0.07% | 96 |
|